ABBV
AbbVie Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$256.31
−1.50%Margins
Gross margin
71.5%
EBITDA margin
33.0%
EBIT margin
29.3%
Net margin
9.8%
FCF margin
30.6%
-106.4%
Return on equity
4.7%
Return on assets
29.1%
Return on invested capital
0.47x
Asset turnover
$19.5B
Cash from operations
$3.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026